Thrivent Financial for Lutherans raised its position in Visteon Co. (NASDAQ:VC – Free Report) by 186.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,542 shares of the company’s stock after buying an additional 13,380 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Visteon were worth $1,822,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of the business. Signaturefd LLC lifted its position in Visteon by 62.5% during the 4th quarter. Signaturefd LLC now owns 684 shares of the company’s stock worth $61,000 after acquiring an additional 263 shares during the period. Cibc World Markets Corp purchased a new stake in shares of Visteon during the fourth quarter worth approximately $227,000. Royce & Associates LP lifted its holdings in shares of Visteon by 39.2% during the fourth quarter. Royce & Associates LP now owns 281,508 shares of the company’s stock worth $24,975,000 after purchasing an additional 79,294 shares during the period. Swiss National Bank grew its position in Visteon by 0.9% in the 4th quarter. Swiss National Bank now owns 54,300 shares of the company’s stock valued at $4,817,000 after buying an additional 500 shares during the last quarter. Finally, Wealthfront Advisers LLC acquired a new position in Visteon in the 4th quarter valued at $1,376,000. 99.71% of the stock is currently owned by hedge funds and other institutional investors.
Visteon Trading Down 1.8 %
NASDAQ:VC opened at $78.35 on Friday. Visteon Co. has a 52-week low of $75.75 and a 52-week high of $119.16. The company has a quick ratio of 1.47, a current ratio of 1.74 and a debt-to-equity ratio of 0.23. The stock has a fifty day simple moving average of $84.08 and a 200-day simple moving average of $88.49. The company has a market capitalization of $2.12 billion, a PE ratio of 7.99, a price-to-earnings-growth ratio of 0.42 and a beta of 1.39.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on VC. Royal Bank of Canada reduced their target price on shares of Visteon from $127.00 to $100.00 and set an “outperform” rating for the company in a research note on Wednesday, February 19th. Wells Fargo & Company lifted their price objective on Visteon from $119.00 to $124.00 and gave the company an “overweight” rating in a report on Wednesday, February 19th. Barclays cut their target price on Visteon from $115.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 3rd. TD Cowen assumed coverage on Visteon in a research note on Friday, March 7th. They issued a “buy” rating and a $108.00 price target on the stock. Finally, Morgan Stanley cut their price objective on Visteon from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, March 3rd. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Visteon presently has a consensus rating of “Moderate Buy” and an average target price of $117.25.
Get Our Latest Research Report on VC
Visteon Profile
Visteon Corporation, an automotive technology company, designs, manufactures, and sells automotive electronics and connected car solutions for vehicle manufacturers worldwide. The company provides instrument clusters, including analog gauge clusters for 2-D and 3-D display-based devices; information displays that integrate a range of user interface technologies and graphics management capabilities, such as active privacy, TrueColor enhancement, local dimming, cameras, optics, haptic feedback, and light effects; and infotainment and connected car solutions, including scalable Android infotainment for seamless connectivity, as well as onboard artificial intelligence-based voice assistants with natural language understanding.
Featured Articles
- Five stocks we like better than Visteon
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- Quiet Period Expirations Explained
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Which Wall Street Analysts are the Most Accurate?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding VC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Visteon Co. (NASDAQ:VC – Free Report).
Receive News & Ratings for Visteon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Visteon and related companies with MarketBeat.com's FREE daily email newsletter.